Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales.
Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales.
Requirement for support of existing Low Density Lipid (LDL) Removal Apheresis Systems.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Fresenius Medical Care (UK) Limited | 03203279 | £100,000 | - |
Government spending data: This supplier has received £25,913,057 in 2,720 payments (over £25k) from Manchester University NHS Foundation Trust, Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT, Royal Cornwall Hospitals NHS Trust and 5 more public bodies (2018-04-19 to 2026-03-26). View full payment history →